Finance

Beta
Lists
ATX:ASX
Amplia Therapeutics Ltd
A$0.14
0.00%
(0.00) 1D
May 29, 4:10:04 PM GMT+10  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for ATX...
Open
A$0.14
High
A$0.14
Low
A$0.13
Mkt. cap
66.82M
Avg. vol.
1.13M
Volume
0.00
52-wk high
A$0.42
52-wk low
A$0.05
EPS
-A$0.02
Shares outstanding
513.31M
No. of employees
1
Open
A$0.14
High
A$0.14
Low
A$0.13
Mkt. cap
66.82M
Avg. vol.
1.13M
Volume
0.00
52-wk high
A$0.42
52-wk low
A$0.05
EPS
-A$0.02
Shares outstanding
513.31M
No. of employees
1
News stories
From sources across the web
About Amplia Therapeutics Ltd
CEO-
Employees1
Founded2000
Headquarters-
SectorBiotechnology
Previous reportsAll values in AUD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in AUD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
1.32M
1.32M
1.43M
1.43M
Cost of goods sold
79.04K
79.04K
113.74K
113.74K
Cost of revenue
79.04K
79.04K
113.74K
113.74K
Research and development expenses
2.50M
2.50M
2.04M
2.04M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
879.98K
879.98K
867.44K
867.44K
Operating expense
3.42M
3.42M
2.97M
2.97M
Total operating expenses
3.50M
3.50M
3.09M
3.09M
Operating income
-2.19M
-2.19M
-1.66M
-1.66M
Other non operating income
-
-
-
-
EBT including unusual items
-2.09M
-2.09M
-1.77M
-1.77M
EBT excluding unusual items
-2.09M
-2.09M
-1.77M
-1.77M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-2.09M
-2.09M
-1.77M
-1.77M
Net profit margin
-158.77%
-158.77%
-123.46%
-123.46%
Earnings per share
-
-
-
-
Interest and investment income
102.26K
102.26K
-
-
Interest expense
-2.30K
-2.30K
-108.65K
-108.65K
Net interest expenses
99.96K
99.96K
-108.65K
-108.65K
Depreciation and amortization charges
18.15K
18.15K
27.92K
27.92K
EBITDA
-2.17M
-2.17M
-1.65M
-1.65M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more